Cigna Group Form 4 insider transactions

Nicole S. Jones, EVP, Chief Administrative Officer and General Counsel of Cigna Group, reports acquisition of restricted stock and stock options.

Brian C. Evanko, EVP, Chief Financial Officer and President & CEO, Cigna Healthcare, reports the acquisition of Cigna Group shares and stock options.

Cigna Group's CEO, David Cordani, reported acquiring shares and stock options, including restricted shares and those through the company's 401(k) plan.

David Brailer, EVP & Chief Health Officer of Cigna Group, reports the acquisition of restricted shares and stock options.

Noelle K. Eder, EVP and Global Chief Information Officer of Cigna Group, reports the acquisition of common stock and stock options.

Director Eric Wiseman reports acquisition of phantom stock units through a deferred compensation plan.

Director George Kurian reported the acquisition of phantom stock units in The Cigna Group through a deferred compensation plan.

David Cordani, Chairman & CEO of Cigna Group, exercised stock options and sold shares of common stock between February 23 and February 27, 2024, under a pre-arranged Rule 10b5-1 trading plan.